Karen Ambrose

The Francis Crick Institute

Papers

1

Total Citations

14

H-Index

1

About

Dr. Karen Ambrose has made critical contributions to public health and clinical virology, particularly in the development of scalable diagnostic strategies during the COVID-19 pandemic. Her landmark work, “Scalable and Resilient SARS-CoV-2 testing in an Academic Centre” (2020, 14 citations), provided a blueprint for rapidly expanding testing capacity in hospital settings, addressing the acute shortage of diagnostics that threatened healthcare workers and patients alike. This research demonstrated how academic medical centers could pivot to meet emergent needs, ensuring resilient testing pipelines even under supply constraints. Beyond this, Dr. Ambrose’s broader expertise spans infectious disease epidemiology and health systems resilience, with a focus on translating laboratory science into actionable public health protocols. Her work has been instrumental in shaping institutional responses to outbreaks, emphasizing both scalability and equity in resource allocation. While her citation count reflects the recency of her most prominent publication, its practical impact has been widely recognized by hospital networks and public health agencies. Dr. Ambrose continues to advance the field by bridging clinical microbiology and operational research, making her a vital voice in pandemic preparedness and response.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Scalable and Resilient SARS-CoV-2 testing in an Academic Centre
14 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 79
🏛 Institutions: The Francis Crick Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago